These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 35544049)

  • 1. Long-acting injectable ART for HIV: a (cautious) step forward.
    Venkatesan P
    Lancet Microbe; 2022 Feb; 3(2):e94. PubMed ID: 35544049
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study.
    van Vliet MM; Hendrickson C; Nichols BE; Boucher CA; Peters RP; van de Vijver DA
    J Int AIDS Soc; 2019 Dec; 22(12):e25427. PubMed ID: 31855323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Acting Injectable Preexposure Prophylaxis for HIV Prevention in South Africa: Is There a Will and a Way?
    Landovitz RJ; Grinsztejn B
    J Infect Dis; 2016 May; 213(10):1519-20. PubMed ID: 26681779
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-acting injectable for HIV approved for use in the UK.
    Kirby T
    Lancet Infect Dis; 2022 Jan; 22(1):26. PubMed ID: 34953553
    [No Abstract]   [Full Text] [Related]  

  • 5. Injectable Antiretroviral Drugs: Back to the Future.
    Berruti M; Riccardi N; Canetti D; Lo Caputo S; Taramasso L; Di Biagio A
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33540877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives of injectable long acting antiretroviral therapies for HIV treatment or prevention: understanding potential users' ambivalences.
    Carillon S; Gallardo L; Linard F; Chakvetadze C; Viard JP; Cros A; Molina JM; Slama L
    AIDS Care; 2020 May; 32(sup2):155-161. PubMed ID: 32189506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Acting Injectable ART and PrEP Among Women in Six Cities Across the United States: A Qualitative Analysis of Who Would Benefit the Most.
    Philbin MM; Bergen S; Parish C; Kerrigan D; Kinnard EN; Reed S; Cohen MH; Sosanya O; Sheth AN; Adimora AA; Cocohoba J; Goparaju L; Golub ET; Vaughn M; Gutierrez JI; Fischl MA; Alcaide M; Metsch LR
    AIDS Behav; 2022 Apr; 26(4):1260-1269. PubMed ID: 34648131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new paradigm for antiretroviral delivery: long-acting cabotegravir and rilpivirine for the treatment and prevention of HIV.
    Bares SH; Scarsi KK
    Curr Opin HIV AIDS; 2022 Jan; 17(1):22-31. PubMed ID: 34871188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of a long-acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076).
    Tolley EE; Li S; Zangeneh SZ; Atujuna M; Musara P; Justman J; Pathak S; Bekker LG; Swaminathan S; Stanton J; Farrior J; Sista N
    J Int AIDS Soc; 2019 Oct; 22(10):e25408. PubMed ID: 31651098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting agents for HIV treatment and prevention.
    Bekker LG
    Nat Med; 2022 Aug; 28(8):1542-1543. PubMed ID: 35869309
    [No Abstract]   [Full Text] [Related]  

  • 11. Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs.
    Shrestha R; DiDomizio EE; Kim RS; Altice FL; Wickersham JA; Copenhaver MM
    J Subst Abuse Treat; 2020 Oct; 117():108058. PubMed ID: 32811633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review.
    Elliott T; Sanders EJ; Doherty M; Ndung'u T; Cohen M; Patel P; Cairns G; Rutstein SE; Ananworanich J; Brown C; Fidler S
    J Int AIDS Soc; 2019 Dec; 22(12):e25419. PubMed ID: 31850686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-exposure Prophylaxis in HIV: Is it Time to Act Now?
    Baidya A; Nischal N; Chandrasekar PH
    J Assoc Physicians India; 2020 Feb; 68(2):89. PubMed ID: 32009374
    [No Abstract]   [Full Text] [Related]  

  • 14. Expectations and acceptability of long-acting injectable antiretrovirals by patients living with HIV/AIDS.
    Palacios C; Wilpotte C; Adda A; Allaf S; Thibaut P; Chas J; Siguier M; Pialoux G
    Infect Dis Now; 2022 Jun; 52(4):238-239. PubMed ID: 35172216
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India.
    Mayer KH; Chandhiok N; Thomas B
    Indian J Med Res; 2016 Feb; 143(2):125-8. PubMed ID: 27121509
    [No Abstract]   [Full Text] [Related]  

  • 16. Equitable access to long-acting PrEP on the way?
    The Lancet Hiv
    Lancet HIV; 2022 Jul; 9(7):e449. PubMed ID: 35777403
    [No Abstract]   [Full Text] [Related]  

  • 17. The Invisible Product: Preferences for Sustained-Release, Long-Acting Pre-exposure Prophylaxis to HIV Among South African Youth.
    Montgomery ET; Atujuna M; Krogstad E; Hartmann M; Ndwayana S; OʼRourke S; Bekker LG; van der Straten A; Minnis AM
    J Acquir Immune Defic Syndr; 2019 Apr; 80(5):542-550. PubMed ID: 30865050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact along the HIV pre-exposure prophylaxis "cascade of prevention" in western Kenya: a mathematical modelling study.
    Bershteyn A; Sharma M; Akullian AN; Peebles K; Sarkar S; Braithwaite RS; Mudimu E
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25527. PubMed ID: 32602669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long acting systemic HIV pre-exposure prophylaxis: an examination of the field.
    Lykins WR; Luecke E; Johengen D; van der Straten A; Desai TA
    Drug Deliv Transl Res; 2017 Dec; 7(6):805-816. PubMed ID: 28612340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV prevention tool is too slow to reach Africa, activists say.
    Green A
    Science; 2022 Jun; 376(6600):1368-1369. PubMed ID: 35737774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.